Updated:
Yuuwa Capital
Yuuwa Capital is a $40M early-stage venture capital firm based in Perth, Western Australia. The firm invests in companies where it can provide capital and...
Yuuwa Capital
Yuuwa Capital is a $40M early-stage venture capital firm based in Perth, Western Australia. The firm invests in companies where it can provide capital and expertise to help founders and early investors. Yuuwa Capital has made 15 investments, including a Series B - II investment in PolyActiva on September 04, 2018.
General information
Firm type
Private Equity
Year founded
2009
Location
Region
Oceania
Country
Australia
City
Perth
Corporate office
Perth, Western Australia, Australia
Principals
Liddy McCall
Co-founder
James Williams
Co-founder
Sector focus
Frequently asked questions
Who runs investment decisions at Yuuwa Capital?
Co-founders Liddy McCall and James Williams handle all aspects of investment and portfolio support. Both have extensive operating backgrounds — McCall in M&A and startup management, Williams in biotechnology invention and executive leadership — and they make decisions as a pair rather than through a large investment committee.
Does Yuuwa participate in fund commitments or only direct deals?
Yuuwa invests directly in portfolio companies rather than acting as a fund-of-funds or committing capital to other managers. The co-founders take board seats and active roles in the companies they back, making direct investment their core engagement model.
Which sectors does Yuuwa Capital avoid?
Yuuwa is exclusively focused on life sciences, including biotechnology, medical devices, and healthcare. It does not invest in generalist technology, software, consumer, or industrials, and maintains no stated exposure to real estate, infrastructure, or natural resources.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: